Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and noncarriers: A longitudinal analysis of BREAST-Q domains Journal Article


Authors: Myers, S. P.; Tadros, A. B.; Sevilimedu, V.; Nelson, J. A.; Le, T.; Garcia, P.; Morrow, M.; Lee, M. K.
Article Title: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and noncarriers: A longitudinal analysis of BREAST-Q domains
Abstract: Introduction: Contralateral prophylactic mastectomy (CPM) is recommended for BRCA mutation carriers; its use in noncarriers relies on patient choice. We characterized differences in satisfaction and well-being after CPM between BRCA carriers and noncarriers. Methods: BREAST-Q data were obtained before and after CPM with immediate reconstruction performed at a single institution from 2016 to 2022. Associations between BRCA status and satisfaction with breasts, psychosocial well-being, and sexual well-being were assessed, with adjustment for preoperative scores and relevant confounders. Results: In total, 149 BRCA carriers and 842 noncarriers were included. Response rates varied over time (preoperative, 56%; 6 months, 78%; 1 year, 51%; 2 years, 52%; 3 years, 59%). BRCA carriers were younger (p < 0.001), with a higher rate of neoadjuvant chemotherapy (p < 0.001). More noncarriers had HR+/HER2- tumors (p < 0.001) and underwent endocrine therapy (p < 0.001). Baseline satisfaction with breasts was higher among BRCA carriers (median [interquartile range] score, 70 [53–82] vs. 58 [48–70]; p = 0.006); psychosocial (p = 0.20) and sexual (p = 0.14) well-being were not significantly different between groups. BRCA carriers had a greater decrease in satisfaction with breasts (p = 0.04) and psychological well-being (p = 0.05) from baseline to 6 months; decrease in sexual well-being (p = 0.38) was not significantly different between groups. On univariate and multivariable analyses, BRCA status was not associated with satisfaction with breasts, sexual well-being, or psychosocial well-being. Conclusions: Satisfaction and well-being were similar between BRCA carriers and noncarriers treated with CPM. Relative to noncarriers, BRCA carriers experienced a greater decline in satisfaction with breasts and psychological well-being at 6 months after CPM. © 2023, Society of Surgical Oncology.
Keywords: adult; controlled study; patient satisfaction; major clinical study; genetics; mutation; adjuvant therapy; postoperative care; antineoplastic agent; preoperative evaluation; prospective study; mastectomy; psychology; breast neoplasms; brca1 protein; brca2 protein; heterozygote; cancer hormone therapy; depression; adjuvant chemotherapy; breast tumor; satisfaction; neoadjuvant chemotherapy; genetic screening; antineoplastic hormone agonists and antagonists; longitudinal study; personal satisfaction; prophylactic mastectomy; contralateral prophylactic mastectomy; triple negative breast cancer; patient-reported outcome; germline mutation; breast-q; invasive breast cancer; humans; human; female; article; hormone receptor positive breast cancer; psychological well-being; breast radiotherapy; human epidermal growth factor receptor 2 negative breast cancer; social well-being; sexual well-being
Journal Title: Annals of Surgical Oncology
Volume: 30
Issue: 12
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2023-11-01
Start Page: 7116
End Page: 7123
Language: English
DOI: 10.1245/s10434-023-14086-y
PUBMED: 37581851
PROVIDER: scopus
PMCID: PMC10996069
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Minna Lee -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    772 Morrow
  2. Paula L Garcia
    21 Garcia
  3. Jonas Allan Nelson
    208 Nelson
  4. Audree Blythe Tadros
    116 Tadros
  5. Tiana Vynguyen Le
    42 Le
  6. Minna Kyu Lee
    23 Lee
  7. Sara Poorfarahani Myers
    18 Myers